ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,714, issued on Aug. 11, was assigned to onCour Pharma Inc. (Northbrook, Ill.).
"Treatment of immune evasive tumors" was invented by John Puisis (Northbrook, Ill.), Adam Elhofy (Northbrook, Ill.), Tushar Murthy (Northbrook, Ill.), Michael Boyne (Northbrook, Ill.) and Joseph Podojil (Northbrook, Ill.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating immune evasive cancers using surface functionalized particles alone or in combination with cancer therapeutics."
The patent was filed on July 31, 2020, under Application No. 17/631,277.
*For further information, including images, charts and tables, please ...